About 17 percent of the faculty members at MD Anderson Cancer Center signed a petition that disagreed with the institution's Faculty Senate in its efforts to step in and improve morale at the Houston-based institution.
When the Lung Master Protocol clinical trial (Lung-MAP or S1400) (1) was launched in June 2014, the goal of this first-of-its kind trial was simple: find effective treatments for seriously ill patients suffering from a specific type of lung cancer.
Work Left UnfinishedSo enough of unmitigated success—let me talk about things that were more problematic, especially what I propose to do and feel I didn't get done.
"All Pull; No Push"—Varmus Describes his Reasons for Leaving in Farewell Town Hall
MD Anderson's message to the American Association of University Professors boils down to this: A pox on your house.
The American Society of Clinical Oncology announced the winners of its Special Awards Program.
Following Harold Varmus's remarks to the Board of Scientific Advisors, Douglas Lowy, soon-to-be acting director of the NCI, focused on reducing the amount of the planned cuts for modular R01 grants.
NCI Director Harold Varmus announced plans to gradually increase in the institute's cancer centers budget over the next four to five years.
There will be no more faculty surveys at MD Anderson, UT System Chancellor William McRaven pledged to the institution's faculty in a closed-door meeting March 18.
New hepatitis C therapies with high price tags and the exploitation of loopholes for compounded medications contributed to a 13.1 percent increase in U.S. drug spending in 2014, a rate not seen in more than a decade, according to the 2014 Express Scripts Drug Trend Report.
